Aspero Medical Receives $310,000 Grant for Development of Pillar™ Micro-Textured Gastrointestinal Endoscopic Balloon Overtube

Gastrointestinal endoscopy focused startup company to expand development effort for novel endoscopic single balloon overtube product line. Aspero Medical, a medical device startup focused on developin...

Learn More

ARCA Biopharma files application for Covid-19 drug treatment

The company has a drug in its arsenal that it believes could be effective in the treatment of Covid-19 patients. Find out more in the Denver Business Journal.

Learn More

Ampio Reports Positive Results in Early Trial for IV Ampion treatment in COVID-19 Patients

Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scaleAmpion-treated patients showed greater improvement compared to patients trea...

Learn More

Proov Lands VC Funds as Demand Surges for its At Home Test Kits

Proov, an at-home hormone testing kit company, has announced funding from two venture capital firms that aim to build up underrepresented founders. The investment – the amount was not disclosed – from...

Learn More

Maker of Mask Designed to treat Chronic Pain Raises 5.8M

Hear from Richard Hanbury, Sana Health Founder, the story of how the company started and the drive behind it all. Hanbury has created a Lafayette-based company known as Sana Health, which produces med...

Learn More

AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.

AnGes, Inc. (“AnGes”), announced today a collaboration agreement with Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company, through which Brickell has the right t...

Learn More

AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy

AveXis is now known as Novartis Gene Therapies, marking another milestone in their journey to be the world’s leading gene therapy company. Novartis has renamed the previously acquired AveXis to Novart...

Learn More

EY Entrepreneur of the Year Finalist list for the Mountain Desert

CBSA sponsor, EY, released the EY Entrepreneur of the Year Finalist list for the Mountain Desert region today. Congratulations and amazing job to CBSA member DMC Biotechnologies, Inc. for being named...

Learn More

Bond Pet Foods Develops Lab-grown Meat Prototype, Plans for 2023 Commercialization

A Boulder food technology company is looking to change the way people think about pet food. Bond Pet Foods has developed a prototype for lab-grown pet food using real meat protein. While the startup i...

Learn More

CBSA Member Mentioned in Crisis Innovators

CBSA members PharmaJet and CirrusMD Inc. are featured in The Business Journals Crisis Innovators: How 8 Colorado Startups are Fighting COVID-19. Across the state, Colorado’s tech and startup innovator...

Learn More